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Canonical Wnt Signaling Induces Skin Fibrosis and
Subcutaneous Lipoatrophy
A Novel Mouse Model for Scleroderma?
Jun Wei,1 Denisa Melichian,1 Kazuhiro Komura,1 Monique Hinchcliff,1 Anna P. Lam,1
Robert Lafyatis,2 Cara J. Gottardi,1 Ormond A. MacDougald,3 and John Varga1
Objective. Because aberrant Wnt signaling has
been linked with systemic sclerosis (SSc) and pulmo-
nary fibrosis, we sought to investigate the effect of
Wnt-10b on skin homeostasis and differentiation in
transgenic mice and in explanted mesenchymal cells.
Methods. The expression of Wnt-10b in patients
with SSc and in a mouse model of fibrosis was investi-
gated. The skin phenotype and biochemical character-
istics of Wnt-10b–transgenic mice were evaluated. The
in vitro effects of ectopic Wnt-10b were examined in
explanted skin fibroblasts and preadipocytes.
Results. The expression of Wnt-10b was increased
in lesional skin biopsy specimens from patients with SSc
and in those obtained from mice with bleomycin-
induced fibrosis. Transgenic mice expressing Wnt-10b
showed progressive loss of subcutaneous adipose tissue
accompanied by dermal fibrosis, increased collagen
deposition, fibroblast activation, and myofibroblast ac-
cumulation. Wnt activity correlated with collagen gene
expression in these biopsy specimens. Explanted skin
fibroblasts from transgenic mice demonstrated persis-
tent Wnt/-catenin signaling and elevated collagen and
-smooth muscle actin gene expression. Wnt-10b infec-
tion of normal fibroblasts and preadipocytes resulted in
blockade of adipogenesis and transforming growth fac-
tor  (TGF)–independent up-regulation of fibrotic
gene expression.
Conclusion. SSc is associated with increased Wnt-
10b expression in the skin. Ectopic Wnt-10b causes loss
of subcutaneous adipose tissue and TGF-independent
dermal fibrosis in transgenic mice. These findings sug-
gest that Wnt-10b switches differentiation of mesenchy-
mal cells toward myofibroblasts by inducing a fibro-
genic transcriptional program while suppressing
adipogenesis. Wnt-10b–transgenic mice represent a
novel animal model for investigating Wnt signaling in
the setting of fibrosis.
Systemic sclerosis (SSc) is characterized by in-
flammation, autoimmunity, small-vessel vasculopathy,
and fibrosis in the skin, lungs, and other target organs
(1). Fibrosis is attributable to excessive synthesis and
deposition of collagens and other extracellular matrix
(ECM) molecules, accompanied by accumulation of
myofibroblasts positive for -smooth muscle actin (-
SMA) (2). The source of ECM-producing activated
mesenchymal cells is controversial (3,4). In situ transi-
tion of resident fibroblasts into myofibroblasts, influx of
bone marrow–derived fibrocytes from the circulation,
and transdifferentiation of epithelial and endothelial
cells into myofibroblasts all might contribute to the
expanded pool of biosynthetically active mesenchymal
cells. Each of these processes is potently induced by
transforming growth factor  (TGF) (5).
The pathogenesis of fibrosis in SSc is multifacto-
rial and involves multiple extracellular cues that are
important for the initiation or propagation of fibrosis
(6). Recent evidence points to the potential importance
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of Wnt proteins in fibrosis. The Wnt family comprises 19
glycoproteins with dual roles in transcriptional regula-
tion and cell–cell adhesion (7). The paracrine effects of
Wnt proteins are mediated via canonical and noncanoni-
cal intracellular pathways. Beta-catenin plays a funda-
mental role in canonical signaling (8). Binding of Wnt
ligands to the cell surface receptors Frizzled and low-
density lipoprotein receptor–related protein 5 (LRP-5)
and LRP-6 results in stabilization and accumulation of
-catenin. In the nucleus, -catenin regulates target
gene expression via the T cell factor family of DNA-
binding transcription factors (9). A large number of
genes with diverse biologic functions are regulated by
-catenin in a highly cell context–specific manner (10).
Transcriptional Wnt targets include Dkk and Axin2
(extracellular and intracellular Wnt inhibitors, respec-
tively), permitting tight regulation of -catenin signaling
via negative feedback.
The Wnt proteins are known primarily as devel-
opment regulators that are essential for normal embry-
onic morphogenesis and cell fate determination, includ-
ing specification of dermal cell identity (11). In the
adult, Wnt proteins regulate pluripotent cell differenti-
ation, tissue repair, and regeneration. Acquired defects
in Wnt expression or function are associated with can-
cer, aging, pulmonary arterial hypertension, rheumatoid
arthritis, osteosclerosis, and osteoporosis (12–14). A
potential role for Wnt proteins in tissue remodeling and
pathologic fibrosis is now emerging. Several genes in-
volved in fibrogenesis are directly regulated by Wnt
proteins, and pathologic fibrosis has been linked to
aberrant Wnt expression and/or activation (15,16). Wnt-
10b has potent effects on adipogenesis and osteoblasto-
genesis (17,18). Transgenic mice in which Wnt-10b is
expressed from the fatty acid binding protein 4 (FABP4)
promoter showed cold intolerance and resistance to
diet-induced obesity (17). Incidentally noted was an
increase in dermal thickness, with a reduced number of
adipocytes in the skin (17).
There are additional observations linking altered
Wnt signaling and cutaneous fibrosis. For instance,
TSK-1 mice show aberrant expression of Wnt proteins
and their endogenous inhibitors in the skin (19). More-
over, skin biopsy specimens from patients with SSc
revealed altered expression of the Wnt signaling axis
(20). Skin and lung, the most prominent targets for
fibrosis in SSc, express all components of the Wnt
pathway, including ligands, receptors, inhibitors, and
intracellular signal transducers. Taken together, these
observations suggest a plausible role for Wnt signaling in
the pathogenesis of fibrosis in patients with SSc.
The results of the current study demonstrate
elevated levels of Wnt-10b and evidence of enhanced
-catenin activity in lesional skin biopsy specimens
obtained from mice with bleomycin-induced sclero-
derma and from patients with diffuse cutaneous SSc. In
transgenic mice, Wnt-10b overexpression resulted in
replacement of subcutaneous adipose tissue with fibrotic
tissue. Explanted transgenic fibroblasts showed persis-
tent Wnt-10b elevation and -catenin signaling in vitro
that were associated with fibrotic gene expression and
reciprocal suppression of adipogenic genes. In normal
fibroblasts and preadipocytes, ectopic Wnt-10b abro-
gated the induction of adipogenesis and promoted
TGF-independent fibrogenesis. These results provide
compelling evidence for the fibrogenic role of Wnt-10b
and suggest that targeting aberrant Wnt-10b expression
or activity might be a novel therapeutic strategy for the
control of pathologic fibrosis.
MATERIALS AND METHODS
Animals and experimental protocols. FABP4–Wnt-
10b–transgenic mice harbor the Wnt-10b gene under the
control of a 7.6-kb fragment of the FABP4 promoter/enhancer
and show ectopic Wnt-10b expression in both white and brown
adipose tissue as well as the bone marrow (17). For this study,
transgenic mice were crossed onto an FVB background, and
heterozygous female mice were studied at 6 months of age.
Each experimental group consisted of 4–6 mice. Animal
protocols were institutionally approved by the Northwestern
University Animal Care and Use Committee. The expression
of Wnt-10b in the skin was examined using a mouse model of
bleomycin-induced scleroderma (21). Lesional skin was har-
vested and analyzed as previously described (21).
To examine Wnt-10b expression in patients with SSc,
4-m–thick sections were prepared from lesional skin biopsy
specimens obtained from 3 patients with diffuse cutaneous SSc
and from the forearms of 3 healthy adults and processed for
immunohistochemical analysis, using anti-mouse Wnt-10b
monoclonal antibodies (1:50 dilution; Santa Cruz Biotechnol-
ogy) (22). Nonspecific goat IgG served as negative control. The
protocol for performing skin biopsies was approved by the
Institutional Review Board for Human Studies.
Histochemical analysis. Consecutive 4-m serial sec-
tions of paraffin-embedded skin were stained with hematoxylin
and eosin. To evaluate collagen content and organization,
deparaffinized sections were stained with Masson’s trichrome
or picrosirius red and viewed under polarized light (23).
Dermal thickness was determined in 5 randomly selected
microscopic fields per slide for each mouse (21). Mast cells
were identified by astra blue staining (24) and quantified in 6
random microscopic fields per mouse.
Immunohistochemistry, quantitation of tissue colla-
gen, and serum adiponectin assays. Deparaffinized skin sec-
tions were treated with target retrieval solution (Dako) and
stained with primary antibodies (1:100 dilution) against
-SMA (Sigma) and phosphorylated Smad2 (Cell Signaling
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Technology). Bound antibodies were detected using secondary
antibodies from the HistoMouse-Max kit (Zymed) and the
DakoCytomation EnVision System-HRP according to the
manufacturers’ instructions. Substitution of primary antibody
with isotype-matched IgG served as a negative control. Sec-
tions were counterstained with hematoxylin and viewed under
an Axioskop microscope (Zeiss). Images were captured by the
Nuance Multiple Spectra CCD system, using Nuance 2.10
software. Semiquantitative evaluation of immunohistochemi-
cal reactions was performed in a blinded manner. The collagen
content of the skin was quantified by colorimetric assays
(Biocolor). Serum adiponectin levels were determined by
enzyme-linked immunosorbent assays (R&D Systems).
RNA isolation and real-time quantitative polymerase
chain reaction (qPCR). Total RNA was isolated from skin
tissue or explanted fibroblasts or preadipocytes and subjected
to qPCR analysis, as previously described (25). Information
regarding the primer pairs used for PCR are available from the
corresponding author. The results of triplicate determinations
are expressed as the fold change in messenger RNA (mRNA)
levels relative to control (36B4) in each sample.
Cell cultures and differentiation assays. Primary fibro-
blast cultures were established by explantation from skin
biopsy specimens obtained from the interscapular region of
transgenic mice and their wild-type (WT) littermates and
studied at early confluence (24). Mouse 3T3-L1 preadipocytes
(American Type Culture Collection) were seeded in 24-well
plates and infected at early confluence with Wnt-10b adenovi-
rus or control green fluorescent protein adenovirus. Cultures
were incubated in differentiation medium (DM2-L; Zen-Bio)
for 48 hours, followed by adipocyte medium (Zen-Bio) for up
to 7 days and stained with oil red O (26). Experiments were
repeated at least 3 times. Cellular oil red O uptake was
quantitated by dissolving in 2-propanol and measuring the
optical density at 510 nm (27). In other experiments, preadi-
pocyte cultures were stained with primary antibodies specific
for perilipin (R&D Systems), type I collagen, adiponectin, and
Alexa 594–conjugated donkey anti-goat IgG or Alexa 488–
conjugated donkey anti-rabbit IgG as secondary antibody.
Nuclei were identified using DAPI. Following stringent wash-
ing, slides were examined using a Zeiss 510 UV Meta confocal
microscope. Each experiment was repeated at least 3 times, with
consistent results. Primary cultures of human dermal fibro-
blasts were established by explantation from neonatal foreskins
and studied between passages 4 and 8 (28). Wnt-10b retrovirus
infections of confluent fibroblasts were performed as previ-
ously described (18). In selected experiments, preadipocytes or
fibroblasts were incubated with the selective ALK-5 inhibitor
SB431542 (10 M) for 5 days.
Western blot analysis and inhibitor of -catenin and
T cell factor 4 pull-down assays. Total protein was extracted
from skin biopsy specimens or explanted fibroblasts. Aliquots
containing equal amounts of proteins (10–15 g) were sub-
jected to Western blot analysis using primary antibodies to
type I collagen (1:400 dilution; Southern Biotechnology),
-SMA (1:5,000; Sigma), FABP4 (1:1,000; BD Biosciences),
active -catenin (1:1,000; Millipore), or GAPDH (1:200; Cell
Signaling Technology) (29). Autoradiograms were scanned,
and band intensities were determined using ImageJ software.
Results were normalized against the intensity of GAPDH in
each sample. The cadherin-free signaling pool of -catenin was
quantitated in whole tissue lysates of mouse skin by affinity
precipitation with glutathione S-transferase immobilized to
glutathione-coupled Sepharose (Sigma) and analyzed by West-
ern blotting, as described previously (30).
Statistical analysis. Results are expressed as the
mean  SD. Student’s t-test was used for comparisons between
2 groups. P values less than 0.05 were considered significant.
Figure 1. Increased cutaneous Wnt-10b expression and activity in patients with systemic sclerosis
(SSc) and in a mouse model of skin fibrosis. A, Representative images of lesional skin biopsy
specimens obtained from patients with diffuse cutaneous SSc (n  3) and healthy control subjects
(n  3). Specimens were examined by immunohistochemistry, using antibodies to Wnt-10b. Arrows
indicate immunopositive cells in the dermis. B, Gene expression levels in lesional skin from mice
injected with bleomycin (bleo) and control mice injected with phosphate buffered saline (PBS).
Total RNA was isolated, and gene expression levels were examined by real-time quantitative
polymerase chain reaction. Results were normalized to 36B4. Bars show the mean  SD of
triplicate determinations.   P  0.05 versus PBS.
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RESULTS
Elevated Wnt-10b expression and activity in fi-
brotic skin. We examined Wnt-10b expression in the
skin obtained from patients with SSc. (Information
regarding the clinical characteristics of the patients is
available from the corresponding author.) Immunohis-
tochemistry revealed only faint expression of Wnt-10b in
skin biopsy specimens obtained from healthy control
subjects, exclusively in the basal layer of the epidermis.
In contrast, Wnt-10b was abundantly expressed in le-
sional skin biopsy specimens from patients with SSc
(Figure 1A). Strong immunoreactivity was seen in epi-
dermal cells as well as in numerous stromal cells within
the densely collagenous dermis.
Next, we examined wnt-10b expression in the skin
of mice with bleomycin-induced scleroderma (31). Fe-
male C57BL/6J mice (8–12 weeks of age) were given
daily subcutaneous injections of phosphate buffered
saline (PBS) or bleomycin for 14 days and were killed on
day 28. A 70% increase in dermal thickness was
evident in the lesional skin of bleomycin-treated mice,
and the subcutaneous adipose layer showed marked
atrophy (results not shown). Real-time qPCR analysis
showed that the expression of wnt-10b mRNA in the
lesional skin of bleomycin-injected mice was increased
4-fold compared with that in PBS-treated controls (Fig-
ure 1B). Moreover, mRNA levels of axin2, a canonical
Wnt target gene, were increased 100-fold (Figure 1B).
Spontaneous dermal fibrosis and adipose tissue
loss in Wnt-10b–transgenic mice. Transgenic mice were
used to investigate the effect of Wnt-10b. The body
weights of FABP4–Wnt-10b–transgenic mice and their
WT littermates, all of which were fed a normal chow diet
for up to 6 months, did not differ significantly (data not
shown). However, a striking loss of visceral fat was
evident in the transgenic mice, with markedly reduced
epididymal and perirenal adipose tissue. Serum levels of
adiponectin, an adipokine produced by adipose tissue,
Figure 2. Spontaneous dermal fibrosis and loss of adipose tissue in Wnt-10b–transgenic (tg)
mice. A, Skin biopsy specimens from 6-month-old wild-type (WT) mice and fatty acid binding
protein 4 (FABP4)–Wnt-10b–transgenic mice, showing hematoxylin and eosin staining (top
panels), immunohistochemistry with antibodies to -smooth muscle actin (-SMA; middle
panels), and astra blue staining (lower panels). Boxed areas show high-magnification ( 400)
views. Dashed lines indicate the extent of the dermis. Arrows indicate -SMA–positive
fibroblasts. B, Dermal thickness in WT and transgenic mice. Bars show the mean  SD of
5 determinations for 4–6 mice in each group. C, Expression of -sma mRNA in the skin of
WT and transgenic mice, as determined by real-time quantitative polymerase chain reaction.
Results were normalized to 36B4 mRNA. Bars show the mean  SD of triplicate determina-
tions for 3–6 mice in each group. D, Number of astra blue–positive cells in the dermis of
WT and transgenic mice, as counted in 6 random microscopic fields per mouse. Bars show the
mean  SD.   P  0.05;   P  0.005 versus WT.
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were reduced by 80% in transgenic mice compared
with WT mice (0.7 g/ml versus 5.6 g/ml; P  0.005).
Examination of the skin revealed abundant subcutane-
ous adipose tissue consisting of 2–3 layers of large
adipocytes in WT mice, whereas adipocytes in Wnt-10b–
transgenic mice were virtually absent from the hypoder-
mis, and adipose tissue was largely replaced by fibrous
tissue (Figure 2A, top panels). Although the epidermis
appeared to be similar in transgenic and WT mice, the
dermal thickness in transgenic mice was increased by
60% (Figure 2B).
The expression of myofibroblasts, which plays a
central role in the development and progression of tissue
fibrosis, was significantly increased in the dermis of
transgenic mice (Figure 2A, middle panels), and the
results of qPCR analysis demonstrated a 50% increase in
-sma mRNA levels (Figure 2C). Although the thick-
ened dermis showed a general paucity of infiltrating
cells, granular cells identified as mast cells by astra blue
staining were present in transgenic mice, generally in
close proximity to dermal blood vessels (Figure 2A,
bottom panels). The number of mast cells in transgenic
mice was increased 3-fold compared with the number
of mast cells in WT controls (Figure 2D).
Correlation between increased skin collagen ac-
cumulation in Wnt-10b–transgenic mice and Wnt activ-
ity. Several approaches were taken to evaluate collagen
accumulation in the skin. Masson’s trichrome and picro-
sirius red stainings showed markedly increased collagen
deposition in the dermis of transgenic mice compared
with their WT littermates (Figure 3A). Collagen fibers in
the dermis of transgenic mice had a woven architecture
distinct from the nearly parallel pattern seen in WT mice
and displayed enhanced refraction under polarized light,
indicating more mature collagen (32). Prominent colla-
gen accumulation between muscle bundles was seen in
transgenic mice but not in their WT littermates. Immu-
noblot analysis showed 2-fold higher levels of collagen in
the dermis of transgenic mice compared with that of WT
controls (Figure 3B). The increase in skin collagen was
confirmed by Sircol assays (data not shown). In contrast,
levels of the adipocyte marker FABP4 were significantly
reduced in transgenic mice (Figure 3C).
The levels of wnt-10b mRNA in the skin, as
determined by qPCR analysis, were 40-fold higher in
transgenic mice compared with their WT littermates
(Figure 4A). To determine whether the Wnt-10b in skin
was biologically active, the levels of axin2 mRNA were
examined. The results showed a 10-fold increase in axin2
mRNA in Wnt-10b–transgenic mice compared with WT
mice. The expression of other markers of canonical Wnt
signaling, such as dkk1, was also significantly elevated in
transgenic mice. Moreover, as shown in Figure 4B,
transgenic mice had elevated levels of activated
-catenin in the skin compared with WT control mice.
Profibrotic gene expression (col1a1, col1a2, and ctgf) was
3–7-fold increased in skin from Wnt-10b–transgenic
mice compared with WT mice (Figure 4C). The in-
creased levels of col1a1 mRNA were strongly correlated
with axin2 mRNA levels in the same tissues (Figure 4D).
In order to determine the role that TGF might
play in mediating Wnt-10b–associated fibrosis, the in
Figure 3. Increased collagen accumulation in the skin of Wnt-10b–
transgenic mice. A, Representative images of skin biopsy specimens
obtained from WT mice and FABP4–Wnt-10b–transgenic mice, show-
ing staining with Masson’s trichrome or picrosirius red. Arrows indi-
cate collagen bundles within muscle layers. Double-headed arrows
indicate the dermal border. Original magnification  200. B and C,
Type I collagen and FABP4 levels, respectively, in the dermis of WT
and transgenic mice, as determined by immunoblot analysis and
densitometry. Results were normalized to GAPDH. Bars show the
mean  SD of triplicate determinations for 4–6 mice in each group. 
 P  0.05;   P  0.005 versus WT. See Figure 2 for definitions.
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situ expression of phosphorylated Smad2, a highly sen-
sitive and specific marker of TGF activity, was as-
sessed. Immunohistochemical analysis showed no signif-
icant difference in the numbers of phosphorylated
Smad2–positive fibroblasts in the dermis of transgenic
mice and WT mice, although the levels of tgf mRNA
were elevated in transgenic mice (data not shown).
Elevated fibrotic gene expression in explanted
transgenic fibroblasts. Fibroblasts are the major cell
population responsible for ECM production in skin.
Because Wnt-10b–transgenic mice showed dermal fibro-
sis, we questioned whether FABP4-driven Wnt-10b ex-
pression was associated with constitutive fibroblast acti-
vation. To address this question, primary skin fibroblast
cultures were established by explantation from Wnt-
10b–transgenic mice and their WT littermates. After 2–3
serial passages, Wnt-10b–transgenic fibroblasts and WT
fibroblasts showed comparable morphologic character-
istics and proliferation rates (data not shown). Confluent
transgenic fibroblasts showed a marked and persistent
elevation in wnt-10b mRNA levels (Figure 5A). Levels of
the canonical Wnt target axin2 showed a 20-fold in-
crease. Col1a1 and col1a2, -sma, and ctgf mRNA
(Figure 5B) and protein levels (Figure 5C) were all
elevated in explanted Wnt-10b–transgenic fibroblasts.
Activation of canonical Wnt signaling in these cells was
detected using antibodies to active -catenin (Figure
5C). At the same time, the expression of the adipogen-
esis markers fabp4, peroxisome proliferator–activated
receptor 1 (ppar1), and ppar2 was diminished in
transgenic fibroblasts (Figure 5D).
To investigate how Wnt signaling modulates ad-
ipogenesis, fibroblasts were incubated with adipocyte
differentiation medium. Under these conditions, WT
fibroblasts readily underwent adipogenesis in response
to DM2. In contrast, fibroblasts explanted from Wnt-
10b–transgenic mice were relatively resistant to the
adipogenic effects of DM2. Consistent with these obser-
vations, real-time qPCR analysis showed that induction
of the adipogenic markers fabp4 and adiponectin was
reduced in transgenic fibroblasts (data not shown).
Role of ectopic Wnt-10b in adipogenesis and
fibrotic responses in vitro. Because dermal fibrosis in
transgenic mice was associated with a reciprocal reduc-
tion in subcutaneous adipose tissue, we next investigated
Wnt-10b–induced regulation of adipogenesis in vitro in
3T3-L1 preadipocytes. In the presence of DM2 adipo-
genic differentiation medium, 3T3-L1 preadipocytes ac-
quired a rounded shape and accumulated prominent oil
red O– and perilipin-positive intracellular lipid droplets
Figure 4. Collagen mRNA expression correlates with elevated Wnt-10b expression and
activity in the skin. A and C, Expression of wnt-10b, axin2, and dkk1 mRNA (A) and of the
profibrotic genes col1a1, col1a2, and ctgf (C) in the skin of WT mice (open bars) and
transgenic mice (solid bars). Results were normalized to 36B4. Bars show the mean  SD
of triplicate determinations for 3–5 mice in each group.   P  0.05. B, Levels of activated
-catenin in the skin of WT mice and FABP4–Wnt-10b–transgenic mice, as determined by
inhibitor of -catenin and T cell factor 4 pull-down assay. Each lane represents an individual
mouse. D, Positive correlation between col1a1 mRNA levels and axin2 mRNA levels in WT
mice (●) and Wnt-10b–transgenic mice (). See Figure 2 for definitions.
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(Figure 6A). Ectopic Wnt-10b inhibited adipogenesis,
with a 70% reduction in oil red O uptake (data not
shown). Real-time qPCR analysis confirmed elevated
expression of wnt-10b and axin2 in Wnt-10b–infected
cells (Figure 6B). Wnt-10b inhibited expression of the
adipogenesis markers ppar, fabp4, and adiponectin in
both unstimulated and DM2-stimulated preadipocytes
(Figure 6C, and results not shown). Moreover, Wnt-10b
induced the expression of fibrogenic genes in preadi-
pocytes while simultaneously diminishing the expression
of adiponectin in the same cells (Figure 6D). Impor-
tantly, treatment of the preadipocytes with the ALK-5
inhibitor SB431542, which blocks canonical TGF sig-
naling, failed to abrogate the up-regulation of collagen
and -SMA gene expression by Wnt-10b (Figure 6E).
The modulation of fibrogenesis by Wnt-10b was
next examined in normal fibroblasts. Confluent foreskin
fibroblasts were infected with Wnt-10b for 5 days. West-
ern blot analysis of whole cell lysates showed a marked
increase in type I collagen levels in Wnt-10b–expressing
fibroblasts (Figure 6F, and results not shown). Incuba-
tion with SB431542 failed to abrogate Wnt-10b–induced
stimulation of collagen and -SMA gene expression in
human fibroblasts (results not shown). The fibrogenic
effects of ectopic Wnt-10b in preadipocytes and dermal
fibroblasts therefore appeared to be independent of
TGF/Smad signaling. Taken together, these results
demonstrate that Wnt-10b is sufficient by itself to cause
stimulation of fibrogenesis markers and reciprocal re-
pression of adipogenesis in mesenchymal cells.
DISCUSSION
Fibrosis in the skin and internal organs is a major
factor contributing to a poor prognosis in SSc. Our
studies provide evidence that Wnt-10b is sufficient to
induce striking skin fibrosis in transgenic mice associated
with replacement of the subcutaneous adipose layers.
These changes are similar to the dermatopathologic
features of scleroderma, in which progressive disease is
associated with replacement of fat by fibrotic tissue and
with characteristic tethering of the skin. The expression
of collagen and connective tissue growth factor (CTGF)
was markedly increased in the skin of Wnt-10b–
transgenic mice, whereas the expression of genes in-
volved in regulating adipogenesis was suppressed. These
observations point to a reciprocal relationship between
adipogenic and fibrogenic gene expression and a crucial
role for Wnt-10b/-catenin signaling in regulating the
developmental balance between adipogenesis and fibro-
genesis. Transgenic skin fibroblasts displayed elevated
Wnt-10b expression and -catenin signaling that were
associated with increased expression of fibrogenesis
markers and resistance to the induction of adipogenesis.
Figure 5. Elevated fibrotic gene expression in explanted Wnt-10b–transgenic mouse fibroblasts
in vitro. A and B, Explanted transgenic (solid bars) and WT (open bars) mouse skin fibroblasts were
examined in parallel. RNA was isolated and subjected to real-time quantitative polymerase chain
reaction (PCR). Results were normalized to 36B4 mRNA. Bars show the mean  SD of triplicate
determinations in a representative experiment. C, Whole cell lysates were examined by immunoblot
analysis. D, Relative mRNA levels were determined by real-time quantitative PCR. Bars show the
mean  SD.   P  0.05 versus WT. cgn  collagen (see Figure 2 for other definitions).
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In mesenchymal cells, ectopic Wnt-10b induced collagen
gene expression while abrogating adipogenesis. These
observations suggest that Wnt-10b induces -catenin
signaling in cutaneous mesenchymal cells, leading to
sustained fibrotic responses.
Transgenic mice expressing Wnt-10b are viable
and appear healthy, implying that despite the inhibitory
effects of Wnt-10b on adipocyte differentiation, neona-
tal adipogenesis is unaffected in these mice (31). This
may indicate that the FABP4 promoter is turned on at a
later stage during development. We observed no signif-
icant differences in weight between WT and transgenic
mice at 6 months of age, despite the substantial reduc-
tion in both subcutaneous and visceral fat deposits,
possibly reflecting a concomitant 33% increase in skin
thickness and weight. Moreover, Wnt-10b–transgenic
mice show increased osteoblastogenesis and bone for-
mation and have increased bone mass (18). Dermal
thickening was associated with marked accumulation of
collagen and increased expression of type I collagen
genes. Multiple lines of evidence indicate that the fibro-
genic effects of Wnt-10b are not mediated through
endogenous TGF. The extent of Smad2 phosphoryla-
tion in lesional skin was comparable in WT and trans-
genic mice, even though tgfb1 mRNA levels were ele-
vated in transgenic mice. Importantly, ectopic Wnt-10b
had no effect of Smad2/3 phosphorylation or TGF
production in explanted lesional fibroblasts. Moreover,
fibrotic responses induced by ectopic Wnt-10b in prea-
dipocytes and fibroblasts were not abrogated by blocking
TGF/Smad signaling using an ALK-5 inhibitor.
Explanted transgenic skin fibroblasts showed per-
sistent Wnt-10b expression and -catenin signaling in
vitro. Constitutive -catenin signaling was associated
with elevated collagen gene expression and a reciprocal
decrease in expression of the adipogenic master regula-
tor PPAR and its target gene FABP4. The expression
of PPAR is known to be suppressed by Wnt-10b in a
variety of cell types (18,33). Multipotent mesenchymal
progenitor cells differentiate into a variety of cell types,
including adipocytes and fibroblasts. PPAR plays a
crucial role in the lineage specification of mesenchymal
progenitor cells (34), and its suppression by canonical
Wnt proteins inhibits adipogenesis while promoting
osteoblastic differentiation of mesenchymal progenitor
cells (35). Activation of -catenin signaling in Wnt-10b–
Figure 6. Ectopic Wnt-10b inhibits adipogenesis and induces fibrotic responses. A–E, Confluent 3T3-L1 cells were infected with green fluorescent
protein adenovirus (AdGFP; open bars in B and C) or AdWnt-10b (solid bars in B and C) for 48 hours. Adipogenic differentiation was induced as
described in Materials and Methods. A, Cultures were fixed after 7 days and stained with oil red O or antiperilipin antibodies (blue indicates staining
with DAPI, and red shows staining with perilipin). Original magnification  200. B and C, RNA was isolated and examined by real-time quantitative
polymerase chain reaction. Results were normalized to 36B4. Bars show the mean  SD of triplicate determinations from a representative
experiment.   P  0.05 versus AdGFP. D, Representative confocal microscopic images are shown, in which green indicates adiponectin and red
shows type I collagen (cgn). Original magnification  400. E, Cultures were infected with AdWnt-10b or AdGFP in the presence or absence of
SB431542 (10 M) for 5 days, and whole cell lysates were subjected to immunoblot analysis. F, Foreskin fibroblasts were infected with Wnt-10b
retrovirus or empty retrovirus for 5 days, and whole cell lysates were subjected to immunoblot analysis. See Figure 2 for other definitions.
1714 WEI ET AL
transgenic skin, and in explanted fibroblasts, was associ-
ated with a substantial reduction in PPAR levels.
Moreover, Wnt-10b dramatically reduced 3T3-L1 pre-
adipocyte differentiation into adipocytes in response to
PPAR ligands in vitro. In normal fibroblasts, ectopic
Wnt-10b induced collagen gene expression. Reduced
PPAR expression and loss of subcutaneous adipose
tissue in transgenic mice were associated with dermal
fibrosis. Taken together, these observations suggest that
ectopic Wnt-10b suppressed the adipogenic programs
and concomitantly stimulated fibrogenic programs in
cutaneous mesenchymal cells, directly contributing to
excessive collagen deposition and fibrosis.
Although Wnt signaling is essential for normal
embryonic development, in adults, aberrant Wnt expres-
sion, regulation, or activity is implicated in cancer, aging,
and a variety of chronic diseases (12–14). Recent evi-
dence from both animal models of fibrosis and human
disorders links aberrant Wnt ligand expression or un-
regulated Wnt activity attributable to, for example, loss
of endogenous inhibitors, with pathologic tissue re-
modeling and fibrosis. Aging-associated fibrosis of
muscle can be attributed to up-regulated Wnt signaling
(36). Transgenic mice with a stabilized mutant form of
-catenin that resists ubiquitin-mediated degradation
(Catnblox[ex3]) showed exuberant wound healing and in-
creased collagen synthesis (37). Genes associated with
tissue remodeling such as plasminogen activator inhibi-
tor 1, CTGF, and fibronectin are known Wnt/-catenin
transcription targets, although the mechanism of their
regulation by Wnt remains ill-defined (38–41). It has
been shown that CTGF induces mesenchymal stem cell
differentiation into fibroblasts, and selective CTGF expres-
sion in fibroblasts results in tissue fibrosis in vivo (42,43).
Patients with idiopathic pulmonary fibrosis (IPF)
have increased nuclear -catenin in the lung (15). More-
over, fibrotic foci showed increased expression of Wnt-
induced signaling protein 1 (WISP-1; a Wnt target gene)
and low-density lipoprotein receptor–related protein 6
and glycogen synthase kinase 3 phosphorylation indic-
ative of activated Wnt signaling at fibroblastic foci
(44,45). Genome-wide transcriptional profiling of the
lungs of patients with IPF revealed elevated expression
of Wnt ligands, Wnt receptors, Wnt regulators, and Wnt
targets such as osteopontin and WISP-1 (45,46), and
explanted IPF fibroblasts maintained enhanced
-catenin activity (41). Importantly, inhibition of Wnt/
-catenin/CREB binding protein signaling reverses
bleomycin-induced pulmonary fibrosis (47). We de-
tected elevated -catenin levels in fibrotic lungs from all
3 SSc patients with advanced lung disease who were
examined (48). Beta-catenin was prominent in epithelial
and fibroblastic cells in fibrotic foci. Several Wnt ligands
are abnormally expressed in the TSK-1 mouse, and
aberrant Wnt expression preceded the appearance of
fibrosis (20). We also detected elevated axin2 mRNA
levels in a mouse model of scleroderma.
Interrogating microarray data sets generated
from expression profiling of SSc skin biopsy specimens
revealed increased mRNA levels of Wnt receptors (e.g.,
Fzd2) and Wnt target genes (e.g., CCND, ASPM),
accompanied by reduced expression of the Wnt inhibi-
tors Wif1 and Dkk2 (20,49, and Wei J, et al: unpublished
observations). Dysregulated Wnt signaling is therefore
associated with pathologic tissue remodeling in the skin
and lungs and is implicated in the excessive matrix
accumulation and myofibroblast differentiation that un-
derlie fibrosis in SSc.
In summary, the results of the current study
demonstrate that FABP4-driven ectopic Wnt-10b ex-
pression in transgenic mice drives -catenin signaling in
the skin associated with marked loss of subcutaneous
adipose tissue, PPAR expression, and adipogenesis,
accompanied by reciprocal dermal fibrosis and TGF-
independent up-regulation of markers of fibrogenesis.
The mechanistic basis for the observed scleroderma
phenotype in Wnt-10b–transgenic mice is likely to in-
volve direct induction of fibrogenic transcription pro-
grams, possibly via induction of fibrogenic cytokines
including CTGF, but remains to be fully elucidated. In
light of the potent inhibitory effects of Wnt-10b on
PPAR expression and activity, our results suggest that
excessive Wnt-10b/-catenin signaling suppresses
PPAR-driven adipogenesis while promoting reciprocal
fibrogenesis. Canonical Wnt signaling might therefore
be an important novel antifibrotic target in SSc and
related fibrosing conditions.
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